Market Players are Arthrex, Inc. (U.S.), Smith & Nephew plc (U.K.), Integra Lifesciences Corporation (U.S.), Wright Medical Technology (U.S.), LifeCell Corporation (U.S.), Organogenesis (U.S.), C.R. Bard, Inc. (U.S.)
(PRWEB) March 25, 2015
The soft tissue repair market is highly competitive, with a large number of players fighting for a larger share. These players are Arthrex, Inc. (U.S.), Smith & Nephew plc (U.K.), LifeCell Corporation (U.S.), C.R. Bard Inc. (U.S.), Johnson & Johnson (U.S.) and Covidien plc (Ireland).
Further Inquiries @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=216009453
Arthrex, Inc. led the orthopedic soft tissue repair market in 2014, mainly because of its broad range of product offerings and strong manufacturing and distribution footprint across the world, which enable it to serve customers in over 100 countries. The company has launched a number of products in this market in the last two years, which has allowed it to expand its resources and capabilities and capitalize on market opportunities. For instance, the company launched products such as The Arthroscopic Chronic AC Repair instrument system, the Minimally Invasive Quad Tendon Harvest System, The MCL Internal Brace Ligament Augmentation Repair and the BioComposite Tenodesis Screw.
LifeCell Corporation led the biological products segment of the soft tissue repair market in 2014. This is attributed to the company’s extensive product portfolio. The synthetic products segment of the market was led by C.R. Bard, Johnson & Johnson and Covidien.
Request for Customization @ http://www.marketsandmarkets.com/requestCustomization.asp?id=216009453
New product launches, mergers & acquisitions, expansions and agreements & collaborations were the key strategies adopted by most companies in the market in 2012 and 2014. New product launches was the preferred growth strategy in that period. The increased demand for better and innovative devices has resulted in an increased number of companies focusing on this strategy, including key players such as Arthrex, Inc. (U.S.), Smith & Nephew plc (U.K.), LifeCell Corporation (U.S.), C.R. Bard, Inc. (U.S.) and Covidien plc (Ireland). Several companies also adopted acquisitions, agreements, collaborations and partnerships as key growth strategies.
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/healthcareit